Beta Bionics (BBNX) Income Statement

Beta Bionics reported revenue of $100.25M in fiscal 2025 (fiscal year ended Dec 31, 2025), up 53.9% from $65.12M a year earlier. Beta Bionics posted a net loss of $73.20M, compared with a net loss of $54.76M a year earlier. Gross margin was 55.4% and operating margin -71.5%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $32.01M, up 37.8% from the same quarter a year earlier.

Beta Bionics Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Beta Bionics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022
Revenue & Gross Profit
Revenue	100.25	65.12	12.00	0.18
Cost of Revenue	44.71	29.24	5.69	0.00
Gross Profit	55.54	35.89	6.31	0.18
Operating Expenses
Research & Development	34.79	26.18	17.94	31.43
Selling, General & Administrative	92.43	54.96	24.22	33.50
Operating Expenses	127.22	81.14	42.16	66.02
Operating Income	-71.68	-45.25	-35.85	-65.84
Other Income/Expense
Interest Income	10.93	3.91	1.78	0.20
Interest Expense	0.00	0.00	0.00	-0.01
Other Income/Expense	-1.52	-9.51	-8.25	1.09
Income
Income Before Tax	-73.20	-54.76	-44.10	-64.75
Income Tax Expense	0.00	0.00	0.00	0.00
Net Income	-73.20	-54.76	-44.10	-64.75
Net Income - Continuous Operations	-73.20	-54.76	-44.10	-64.75
Net Income - Discontinued Operations	-	-	-	-
EBITDA	-70.32	-44.10	-42.87	-63.40
EBIT	-71.68	-45.25	-35.85	-64.74
Depreciation & Amortization	2.88	1.15	1.23	1.35
Earnings Per Share
Basic EPS	-2.00	-9.00	-1.00	-13.00
Diluted EPS	-2.00	-9.00	-1.00	-13.00
Basic Shares Outstanding	40.53	6.37	42.86	5.00
Diluted Shares Outstanding	40.53	6.37	42.86	5.00

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Beta Bionics Financial Statements

What was Beta Bionics's revenue in fiscal 2025?

Beta Bionics reported revenue of $100.25M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 53.9% from $65.12M a year earlier.

Is Beta Bionics profitable?

No. Beta Bionics reported a net loss of $73.20M in fiscal 2025. In fiscal 2024 it lost $54.76M.

What is Beta Bionics's operating margin?

Beta Bionics's operating income was −$71.68M on revenue of $100.25M in fiscal 2025, an operating margin of -71.5%, compared with -69.5% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition